0001209191-19-023196.txt : 20190403 0001209191-19-023196.hdr.sgml : 20190403 20190403164257 ACCESSION NUMBER: 0001209191-19-023196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: During Matthew CENTRAL INDEX KEY: 0001704631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 19729586 MAIL ADDRESS: STREET 1: C/O OVID THERAPEUTICS INC. STREET 2: 1460 BROADWAY, SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-04-01 0 0001636651 Ovid Therapeutics Inc. OVID 0001704631 During Matthew C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 1 0 1 0 Stock Option (Right to Buy) 1.76 2019-04-01 4 A 0 75000 0.00 A 2029-03-31 Common Stock 75000 75000 D 25% of the shares will become exercisable immediately and the remaining shares shall vest monthly thereafter over subsequent three years subject to the Reporting Person's continued service through such date. /s/ Danielle Mann for Matthew During by POA 2019-04-03